Compare PRVA & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRVA | HTGC |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Retail: Computer Software & Peripheral Equipment | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 2021 | N/A |
| Metric | PRVA | HTGC |
|---|---|---|
| Price | $23.43 | $15.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $30.71 | $18.50 |
| AVG Volume (30 Days) | 747.9K | ★ 2.0M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 11.99% |
| EPS Growth | ★ 63.64 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $2,122,842,000.00 | N/A |
| Revenue This Year | $14.66 | $11.18 |
| Revenue Next Year | $10.48 | $5.24 |
| P/E Ratio | $130.22 | ★ $8.61 |
| Revenue Growth | ★ 22.26 | N/A |
| 52 Week Low | $18.78 | $13.70 |
| 52 Week High | $26.51 | $19.67 |
| Indicator | PRVA | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 60.78 |
| Support Level | $23.27 | $13.77 |
| Resistance Level | $24.13 | $19.63 |
| Average True Range (ATR) | 0.65 | 0.40 |
| MACD | 0.30 | 0.17 |
| Stochastic Oscillator | 93.96 | 89.33 |
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.